Literature DB >> 19262572

MicroRNAs--the micro steering wheel of tumour metastases.

Milena S Nicoloso1, Riccardo Spizzo, Masayoshi Shimizu, Simona Rossi, George A Calin.   

Abstract

Recently, microRNAs (miRNAs) have been discovered to have a role in metastasis. Here we describe how miRNAs are involved in advanced stages of tumour progression, stressing their roles as metastasis activators or suppressors, and discuss their possible use in the clinic as predictive markers and as therapeutic strategies for patients with metastases. Furthermore, we develop the concept that the same miRNAs could be involved both in the cancer stem cell phenotype and in the ability of specific cancer cells to produce metastases, thus representing a mechanistic link between the initial and the final steps of tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19262572     DOI: 10.1038/nrc2619

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  107 in total

Review 1.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

Authors:  Héctor Peinado; David Olmeda; Amparo Cano
Journal:  Nat Rev Cancer       Date:  2007-05-17       Impact factor: 60.716

2.  p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion.

Authors:  Gustavo Baldassarre; Barbara Belletti; Milena S Nicoloso; Monica Schiappacassi; Andrea Vecchione; Paola Spessotto; Andrea Morrione; Vincenzo Canzonieri; Alfonso Colombatti
Journal:  Cancer Cell       Date:  2005-01       Impact factor: 31.743

3.  NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses.

Authors:  Konstantin D Taganov; Mark P Boldin; Kuang-Jung Chang; David Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-02       Impact factor: 11.205

4.  A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors.

Authors:  P Mathijs Voorhoeve; Carlos le Sage; Mariette Schrier; Ad J M Gillis; Hans Stoop; Remco Nagel; Ying-Poi Liu; Josyanne van Duijse; Jarno Drost; Alexander Griekspoor; Eitan Zlotorynski; Norikazu Yabuta; Gabriella De Vita; Hiroshi Nojima; Leendert H J Looijenga; Reuven Agami
Journal:  Cell       Date:  2006-03-24       Impact factor: 41.582

Review 5.  Exploring a new twist on tumor metastasis.

Authors:  Jing Yang; Sendurai A Mani; Robert A Weinberg
Journal:  Cancer Res       Date:  2006-05-01       Impact factor: 12.701

6.  Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis.

Authors:  Erik Sahai; Christopher J Marshall
Journal:  Nat Cell Biol       Date:  2003-08       Impact factor: 28.824

7.  Unique microRNA molecular profiles in lung cancer diagnosis and prognosis.

Authors:  Nozomu Yanaihara; Natasha Caplen; Elise Bowman; Masahiro Seike; Kensuke Kumamoto; Ming Yi; Robert M Stephens; Aikou Okamoto; Jun Yokota; Tadao Tanaka; George Adrian Calin; Chang-Gong Liu; Carlo M Croce; Curtis C Harris
Journal:  Cancer Cell       Date:  2006-03       Impact factor: 31.743

8.  MicroRNAs regulate synthesis of the neurotransmitter substance P in human mesenchymal stem cell-derived neuronal cells.

Authors:  Steven J Greco; Pranela Rameshwar
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-13       Impact factor: 11.205

Review 9.  Role of microRNAs in vascular diseases, inflammation, and angiogenesis.

Authors:  Carmen Urbich; Angelika Kuehbacher; Stefanie Dimmeler
Journal:  Cardiovasc Res       Date:  2008-06-11       Impact factor: 10.787

10.  Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells.

Authors:  Yoshimasa Saito; Jeffrey M Friedman; Yoshitomo Chihara; Gerda Egger; Jody C Chuang; Gangning Liang
Journal:  Biochem Biophys Res Commun       Date:  2008-12-29       Impact factor: 3.322

View more
  349 in total

Review 1.  MicroRNAs, wild-type and mutant p53: more questions than answers.

Authors:  Matthew Jones; Ashish Lal
Journal:  RNA Biol       Date:  2012-06-01       Impact factor: 4.652

2.  miR-193a-3p functions as a tumor suppressor in lung cancer by down-regulating ERBB4.

Authors:  Hongwei Liang; Minghui Liu; Xin Yan; Yong Zhou; Wengong Wang; Xueliang Wang; Zheng Fu; Nan Wang; Suyang Zhang; Yanbo Wang; Ke Zen; Chen-Yu Zhang; Dongxia Hou; Jing Li; Xi Chen
Journal:  J Biol Chem       Date:  2014-11-12       Impact factor: 5.157

3.  miR-200c inhibits invasion and migration in human colon cancer cells SW480/620 by targeting ZEB1.

Authors:  Mian Ling Chen; Liu Sen Liang; Xiao Kang Wang
Journal:  Clin Exp Metastasis       Date:  2012-03-10       Impact factor: 5.150

Review 4.  Non-coding RNAs in human disease.

Authors:  Manel Esteller
Journal:  Nat Rev Genet       Date:  2011-11-18       Impact factor: 53.242

5.  High dose glargine alters the expression profiles of microRNAs in pancreatic cancer cells.

Authors:  Wei-Guang Li; Yao-Zong Yuan; Min-Min Qiao; Yong-Ping Zhang
Journal:  World J Gastroenterol       Date:  2012-06-07       Impact factor: 5.742

6.  Targeting microRNAs with small molecules: from dream to reality.

Authors:  S Zhang; L Chen; E J Jung; G A Calin
Journal:  Clin Pharmacol Ther       Date:  2010-04-28       Impact factor: 6.875

7.  Antagonizing metastasis.

Authors:  Michele De Palma; Luigi Naldini
Journal:  Nat Biotechnol       Date:  2010-04       Impact factor: 54.908

Review 8.  Implication of microRNAs in drug resistance for designing novel cancer therapy.

Authors:  Fazlul H Sarkar; Yiwei Li; Zhiwei Wang; Dejuan Kong; Shadan Ali
Journal:  Drug Resist Updat       Date:  2010-03-17       Impact factor: 18.500

9.  Role of TRPV4 in matrix stiffness-induced expression of EMT-specific LncRNA.

Authors:  Shweta Sharma; Li Ma; Shaik O Rahaman
Journal:  Mol Cell Biochem       Date:  2020-07-30       Impact factor: 3.396

Review 10.  Non-coding RNA regulation of endothelial and macrophage functions during atherosclerosis.

Authors:  Binod Aryal; Yajaira Suárez
Journal:  Vascul Pharmacol       Date:  2018-03-15       Impact factor: 5.773

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.